Precision Medicine Group

Precision Medicine Group is a brand that was founded in 2012 with the aim of transforming the process of bringing new drugs to market. They achieve this by integrating science, technology, data, and human expertise. The company invests organically and acquires capabilities to address the necessary changes in healthcare for global health and outcomes improvement. Co-founded by Mark P. Clein and Ethan D. Leder, experienced entrepreneurs in the healthcare industry, Precision Medicine Group has created cutting-edge businesses, producing thousands of jobs and significant value for shareholders. Currently, the company has over 3200 employees globally, all dedicated to accelerating development and access to breakthrough treatments to improve the lives of patients in need. Precision Medicine Group offers a wide range of services, from advanced lab sciences to translational informatics, regulatory affairs, payer insights, and marketing communications. They help pharmaceutical and life-sciences clients overcome challenges in product development and commercialization in the ever-evolving healthcare landscape.